checkAd

     317  0 Kommentare Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules - Seite 3

    Contact:
    Jaclyn Jaffe
    Avenue Therapeutics, Inc.
    (781) 652-4500
    ir@avenuetx.com


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Avenue Therapeutics Announces $3.25 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules - Seite 3 MIAMI, Jan. 27, 2023 (GLOBE NEWSWIRE) - Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous …